Monitor whether the sale is actually executed and if other insiders follow with similar filings. The proposed sale is routine and not indicative of operational concerns.
Price Chart
Executive Summary
Director James C. Foster filed a Form 144 notice of intent to sell 24,042 shares of Charles River Laboratories common stock, with an estimated aggregate market value of approximately $8.4 million based on the filing date. The shares are to be sold through UBS Financial Services and were acquired via stock option exercise. This is a routine insider sale by a director, not a C-suite officer, and the dollar amount is modest relative to the company's multi-billion-dollar market cap.
Key Facts
- Director James C. Foster filed Form 144 to sell 24,042 shares of CRL common stock.
- Estimated aggregate market value of the proposed sale is $8,414,700.
- Shares were acquired through exercise of stock options on October 22, 2026.
- Sale is to be executed through UBS Financial Services Inc.
- Foster held 33,561 shares as of August 25, 2026 (valued at ~$10.07M) and 28,733 shares as of August 10, 2026 (valued at ~$7.9M), indicating recent accumulation.
Financial Impact
Proposed sale of 24,042 shares valued at ~$8.4M; represents a small fraction of the company's market cap.
Risk Factors
- Insider selling can sometimes signal reduced confidence, but this is a single director's routine diversification sale.
- Form 144 is an intent to sell; the actual sale may not occur.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001969223-26-001084 |
| Document: 0001969223-26-001084-index.html | 0001969223-26-001084 |
| Document: 0001969223-26-001084.txt | 0001969223-26-001084 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | Insider Cluster | $357.41 | awaiting T+20 | awaiting T+20 | $373.64 (+4.54%) |
Oct 22, 2026 5d ago | 144 | $345.37 | awaiting T+20 | awaiting T+20 | $373.64 (+8.19%) |
Oct 21, 2026 6d ago | Institutional Cluster | $339.66 | awaiting T+20 | awaiting T+20 | $373.64 (+10.01%) |
Sep 24, 2026 4w ago | 8-K | $294.44 $339.66 | ▲ +15.36% | ▲ +15.78% | $373.64 (+26.90%) |
Aug 27, 2026 8w ago | Insider Cluster | $291.50 $294.59 | ▲ +1.06% | ▲ +1.55% | $373.64 (+28.18%) |
Aug 20, 2026 9w ago | Insider Cluster | $295.19 $279.01 | ▼ −5.48% | ▼ −6.50% | $373.64 (+26.58%) |
Aug 13, 2026 10w ago | Insider Cluster | $280.05 $273.11 | ▼ −2.48% | ▼ −0.49% | $373.64 (+33.42%) |
Aug 11, 2026 11w ago | Insider Cluster | $284.37 $273.00 | ▼ −4.00% | ▼ −2.10% | $373.64 (+31.39%) |
Aug 10, 2026 11w ago | Insider Cluster | $282.00 $278.35 | ▼ −1.29% | ▼ −0.24% | $373.64 (+32.50%) |
Aug 5, 2026 12w ago | 8-K | $260.72 $291.76 | ▲ +11.91% | ▲ +12.51% | $373.64 (+43.31%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers